Literature DB >> 1352060

Modulation of MK-801 response by dopaminergic agents in mice.

A Verma1, S K Kulkarni.   

Abstract

Various doses of the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonists, MK-801 (0.1-0.5 mg/kg) and ketamine (2.5-10 mg/kg), produced a dose-dependent increase in stereotypic behaviour in naive mice. MK-801 (0.1 mg/kg) and ketamine (2.5 mg/kg) potentiated the stereotypic response of apomorphine (0.1-0.5 mg/kg) in mice pretreated with reserpine (5 mg/kg, 24 h prior) and alpha-methyl-p-tyrosine (150 mg/kg, 1 h prior) but not in naive mice. SKF 38393, a D1 dopamine agonist, enhanced whereas B-HT 920, a D2 dopamine agonist, reduced the stereotypic response of MK-801 in naive mice. The response of MK-801 was blocked by pretreatment with haloperidol (0.5 mg/kg), molindone (2.5 mg/kg), clozapine (7.5 mg/kg) and SCH 23390 (0.1 mg/kg). The present data suggest involvement of endogenous DA transmission in the stimulant action of non-competitive NMDA antagonists in mice. Dopamine D1 and D2 receptor stimulation, respectively, exert opposing effects on the behavioral expression of MK-801 in mice.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352060     DOI: 10.1007/bf02245171

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.

Authors:  M Hiramatsu; A K Cho; T Nabeshima
Journal:  Eur J Pharmacol       Date:  1989-08-03       Impact factor: 4.432

Review 2.  Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia.

Authors:  D C Javitt
Journal:  Hillside J Clin Psychiatry       Date:  1987

Review 3.  Sigma receptors: biology and function.

Authors:  J M Walker; W D Bowen; F O Walker; R R Matsumoto; B De Costa; K C Rice
Journal:  Pharmacol Rev       Date:  1990-12       Impact factor: 25.468

4.  On the mode of action of apomorphine.

Authors:  B Costall; R J Naylor
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

5.  Phencyclidine-induced ipsilateral rotation in rats with unilateral 6-hydroxydopamine-induced lesions of the substantia nigra.

Authors:  R G Fessler; R D Sturgeon; H Y Meltzer
Journal:  Life Sci       Date:  1979-04-02       Impact factor: 5.037

6.  The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice.

Authors:  M Carlsson; A Carlsson
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

7.  Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior.

Authors:  L D Snell; K M Johnson
Journal:  J Pharmacol Exp Ther       Date:  1985-10       Impact factor: 4.030

8.  Striatal glutamatergic function: modifications following specific lesions.

Authors:  P J Roberts; G J McBean; N A Sharif; E M Thomas
Journal:  Brain Res       Date:  1982-03-04       Impact factor: 3.252

9.  The emetic effect of B-HT 920 and apomorphine in the dog: antagonism by haloperidol.

Authors:  W H Hsu; D D Schaffer; D C Dyer
Journal:  Life Sci       Date:  1986-09-15       Impact factor: 5.037

10.  Concomitant D1 dopamine receptor activation (SKF 38393) unmasks D2 dopaminergic actions of B-HT 920 in mice.

Authors:  A Verma; S K Kulkarni
Journal:  Indian J Exp Biol       Date:  1991-02       Impact factor: 0.818

View more
  9 in total

1.  Effect of NMDA receptor antagonists on D1, D2 and D1/D2 mediated behaviors in intact rats.

Authors:  R Dall'Olio; R Rimondini; O Gandolfi
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

2.  Toluene exposure during the brain growth spurt reduces behavioral responses to noncompetitive N-methyl-D-aspartate receptor antagonists in adult rats.

Authors:  Te-Hsiung Chien; Ming-Huan Chan; Yu-Chi Tang; Hwei-Hsien Chen
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

3.  The disruptive effects of ketamine on passive avoidance learning in mice: involvement of dopaminergic mechanism.

Authors:  Y Uchihashi; H Kuribara; Y Isa; T Morita; T Sato
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530

4.  The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function.

Authors:  R Dall'Olio; R Rimondini; O Gandolfi
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

5.  MK-801 induced stereotypies in rats are decreased by haloperidol and increased by diazepam.

Authors:  S Behrens; W F Gattaz
Journal:  J Neural Transm Gen Sect       Date:  1992

6.  Repeated ketamine administration produces up-regulation of muscarinic acetylcholine receptors in the forebrain, and reduces behavioral sensitivity to scopolamine in mice.

Authors:  T Morita; S Hitomi; S Saito; T Fujita; Y Uchihashi; H Kuribara
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

7.  D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.

Authors:  A Verma; S K Kulkarni
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors.

Authors:  R Corbett; F Camacho; A T Woods; L L Kerman; R J Fishkin; K Brooks; R W Dunn
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

9.  Galphimia glauca and Natural Galphimines Block Schizophrenia-Like Symptoms Induced with Apomorphine and MK-801 in Mice.

Authors:  Mayra Alejandra Santillán-Urquiza; Maribel Herrera-Ruiz; Alejandro Zamilpa; Enrique Jiménez-Ferrer; Rubén Román-Ramos; Elian Yuritzi Alegría-Herrera; Jaime Tortoriello
Journal:  Evid Based Complement Alternat Med       Date:  2019-07-21       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.